Showing posts with label 23andme. Show all posts
Showing posts with label 23andme. Show all posts
Friday, April 20, 2012
Thursday, March 22, 2012
InVite Study in Metastatic Breast Cancer/Avastin - 23andMe and Genentech study (U.S.)
InVite Study in Metastatic Breast Cancer - 23andMe
Who is Eligible
- Diagnosed with breast cancer by a medical professional
- Currently have metastatic (stage IV) or recurrent breast cancer
- Treated with bevacizumab (also known as Avastin®) at any point in 2010 and/or 2011*
- Live in the United States
- Age 18 or older
*If you were treated with bevacizumab (also known as
Avastin®) after 2011, and are interested in possible future
opportunities to participate, please email
invite-study@23andme.com.
invite-study@23andme.com.
What You Get
- Convenient and easy opportunity to participate in new type of research
- Help advance medical research in metastatic breast cancer and its treatment
- Receive updates about research progress and discoveries
- Learn about your health and ancestry through FREE access to 23andMe's Personal Genome Service
Subscribe to:
Posts
(
Atom
)
